WallStSmart
UTHR

United Therapeutics Corporation

NASDAQ: UTHR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$571.07
+0.34% today

Updated 2026-04-29

Market cap
$25.03B
P/E ratio
20.48
P/S ratio
7.86x
EPS (TTM)
$27.89
Dividend yield
52W range
$272 – $608
Volume
0.6M

United Therapeutics Corporation (UTHR) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$159.63M$210.94M$281.50M$369.85M$603.83M$743.18M$916.08M$1.12B$1.29B$1.47B$1.60B$1.73B$1.63B$1.45B$1.48B$1.69B$1.94B$2.33B$2.88B$3.18B
Revenue growth (YoY)+32.1%+33.4%+31.4%+63.3%+23.1%+23.3%+21.9%+15.4%+13.8%+9.1%+7.9%-5.7%-11.0%+2.4%+13.6%+14.9%+20.2%+23.6%+10.6%
Cost of revenue$17.03M$22.26M$30.07M$45.32M$73.47M$88.90M$119.30M$131.13M$125.88M$69.04M$72.70M$105.70M$198.70M$117.60M$108.10M$122.50M$146.70M$257.50M$309.70M$384.40M
Gross profit$142.60M$188.68M$251.43M$324.53M$530.37M$654.28M$796.78M$985.86M$1.16B$1.40B$1.53B$1.62B$1.43B$1.33B$1.38B$1.56B$1.79B$2.07B$2.57B$2.80B
Gross margin89.3%89.4%89.3%87.7%87.8%88.0%87.0%88.3%90.2%95.3%95.5%93.9%87.8%91.9%92.7%92.7%92.4%88.9%89.2%87.9%
R&D$57.57M$83.35M$239.18M$122.19M$166.76M$180.01M$173.39M$299.35M$242.55M$245.10M$147.60M$264.60M$357.90M$1.18B$357.70M$540.10M$322.90M$408.00M$481.00M$550.00M
SG&A$54.03M$99.03M$94.31M$176.34M$199.60M$156.48M$201.75M$394.01M$299.29M$358.31M$232.20M$265.80M$206.70M$275.50M$369.00M$402.60M$416.20M$395.30M$542.30M$731.10M
Operating income$28.98M$6.30M$-82.06M$26.00M$164.00M$317.78M$421.65M$292.50M$538.80M$699.01M$1.06B$814.90M$805.40M$-187.60M$593.60M$555.90M$979.70M$1.18B$1.38B$1.49B
Operating margin18.2%3.0%-29.1%7.0%27.2%42.8%46.0%26.2%41.8%47.7%66.4%47.2%49.5%-12.9%40.0%33.0%50.6%50.9%47.9%46.9%
EBITDA$28.98M$22.18M$-67.75M$43.04M$185.47M$341.02M$484.45M$323.76M$575.02M$1.08B$1.09B$1.05B$838.40M$-74.90M$646.30M$736.80M$1.04B$1.39B$1.65B$1.82B
EBITDA margin18.2%10.5%-24.1%11.6%30.7%45.9%52.9%29.0%44.6%73.8%68.2%61.1%51.5%-5.2%43.6%43.7%53.7%59.6%57.5%57.2%
EBIT$27.52M$21.23M$-72.28M$31.64M$167.55M$320.48M$457.31M$292.50M$542.77M$1.05B$1.06B$1.02B$802.50M$-120.80M$596.40M$686.90M$989.00M$1.33B$1.58B$1.73B
Interest expense$482000.00$2.17M$16000.00$12.88M$19.71M$21.37M$16.64M$18.06M$17.59M$4.74M$3.90M$9.00M$13.90M$44.20M$23.50M$18.60M$32.40M$59.30M$42.90M$19.50M
Income tax$-34.06M$-3.28M$-29.51M$-695000.00$41.92M$81.87M$136.23M$104.34M$185.11M$392.80M$346.50M$351.60M$169.70M$-60.50M$124.10M$118.10M$223.30M$289.50M$343.90M
Effective tax rate-85.3%-19.8%40.8%-3.7%28.4%27.3%30.9%37.4%35.2%37.6%32.7%45.7%22.4%36.7%19.4%19.9%23.5%22.7%22.3%0.0%
Net income$73.97M$19.86M$-42.79M$19.46M$105.92M$217.87M$304.44M$174.56M$340.07M$651.64M$713.70M$417.90M$589.20M$-104.50M$514.80M$475.80M$727.30M$984.80M$1.20B$1.33B
Net income growth (YoY)-73.2%-315.5%+145.5%+444.2%+105.7%+39.7%-42.7%+94.8%+91.6%+9.5%-41.4%+41.0%-117.7%+592.6%-7.6%+52.9%+35.4%+21.4%+11.7%
Profit margin46.3%9.4%-15.2%5.3%17.5%29.3%33.2%15.6%26.4%44.5%44.6%24.2%36.2%-7.2%34.7%28.2%37.6%42.3%41.5%41.9%